Clinical Trial Update: TBTC Study 29: Rifapentine During Intensive Phase Tuberculosis (TB) Treatment [Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of TBTC Study 29, a Phase 2 trial evaluating rifapentine during the intensive phase of pulmonary tuberculosis …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Drugs mentioned

• rifapentine (rifapentine)

Snippet

Sponsor: Centers for Disease Control and Prevention | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED